Author: Bingyi Yang; Justin Lessler; Huachen Zhu; Chaoqiang Jiang; Jonathan M. Read; James A Hay; Kin On Kwok; Ruiyin Shen; Yi Guan; Steven Riley; Derek A.T. Cummings
Title: Life course exposures continually shape antibody profile and risk of seroconversion to influenza Document date: 2020_1_16
ID: cyxn7dpw_5
Snippet: Here, we describe paired antibody profiles measured at two time points (baseline from 2009 to 2011 and follow-up from 2014 to 2015), roughly four years apart, in a large sample of individuals from an ongoing cohort study in Guangzhou, Guangdong Province, China (17) . We measured immune responses to multiple chronologically ordered H3N2 influenza strains (referred to as antibody profiles) that represent the history of H3N2 circulation in humans si.....
Document: Here, we describe paired antibody profiles measured at two time points (baseline from 2009 to 2011 and follow-up from 2014 to 2015), roughly four years apart, in a large sample of individuals from an ongoing cohort study in Guangzhou, Guangdong Province, China (17) . We measured immune responses to multiple chronologically ordered H3N2 influenza strains (referred to as antibody profiles) that represent the history of H3N2 circulation in humans since its emergence in 1968. We aim to determine how those profiles vary across individuals and between study visits, and to test if there exist features of these antibody profiles that are more predictive of the risk of seroconversion to recently circulating strains than homologous titers only.
Search related documents:
Co phrase search for related documents- antibody profile and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- antibody profile and seroconversion risk: 1
- antibody profile and time point: 1
- cohort study and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cohort study and immune response measure: 1
- cohort study and large sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- cohort study and roughly year: 1
- cohort study and seroconversion risk: 1, 2, 3, 4, 5, 6, 7, 8
- cohort study and study visit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- cohort study and time point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cohort study and time point measure: 1, 2
- homologous titer and immune response: 1
- homologous titer and seroconversion risk: 1, 2, 3
- immune response and large sample: 1, 2, 3, 4, 5, 6, 7
- immune response and seroconversion risk: 1, 2
- immune response and time point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- immune response measure and time point: 1
- individual large sample and large sample: 1, 2, 3, 4, 5
- large sample and time point: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date